biomedical biotechnology News
-
Terray Therapeutics Expands Scientific Advisory Board to Advance AI-Driven Small Molecule Drug Discovery
Terray Therapeutics, a biotechnology company propelling drug discovery into the information age, today announced the appointment of Fiona Black, PhD to its Scientific Advisory Board, adding valuable expertise in interdisciplinary technology development of both market-leading, end-to-end product solutions and operationally efficient and scalable manufacturing processes. “We are thrilled to ...
-
BIO Welcomes Mississippi Biotechnology Association to Industry Council
Today the Biotechnology Industry Organization (BIO) announced that a newly-formed bioscience organization in Mississippi has joined the Council of State Bioscience Associations (CSBA), an autonomous group of state affiliates operating within BIO. “We are pleased to welcome the Mississippi Biotechnology Association (MS BIO) as a member of the CSBA," said ...
-
Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins
Metabolomics, a subdivision of Creative Proteomics, is dedicated to providing metabolomics services based on cutting-edge LC-MS technology for biomedical research institutions, biotechnology companies, and pharmaceutical companies. Creative Proteomics has developed highly sensitive, selective and accurate LC/MS/MS analytical solutions for the identification and quantification of vitamins in ...
-
TIKOMED’S ILB® restores brain energy metabolism following severe traumatic brain injury in the rat demonstrated in data published by the journal Antioxidants
A new study on TIKOMED’s lead drug candidate, ILB®, addressing one of the underlying causes of neurodegeneration in acute and chronic diseases was published in Antioxidants today. The data from the rodent model studying severe traumatic brain injury (sTBI), showed that a single post-injury injection of ILB® has beneficial effects on the metabolic damages caused by sTBI. “This ...
By TIKOMED AB
-
Creative Proteomics Lipidomics Announces Exosomes Lipidomics Service to Identify Lipid-based Biomarkers
Lipidomics, a division of Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnology and pharmaceutical companies. The product manager has recently announced the fully-developed exosomes lipidomics service to help identify lipid-based biomarkers and unravel its monitoring function in diseases. ...
-
The MALDI-Imaging Lipidomics Service Is Now Available Through Lipidomics Platform
As a division of Creative Proteomics, Lipidomics is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnology and pharmaceutical companies. The company has recently announced the fully-developed MALDI-Imaging Lipidomics Service to research the distribution of lipids in tissues. Lipidomics MALDI imaging mass ...
-
Creative Proteomics Metabolomics Launches Animal Untargeted Metabolomics Solutions for Scientific Research
Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS based metabolomics services for biomedical research institutions, biotechnology and pharmaceutical companies. Creative Proteomics has deep industry and business process expertise, global resources, and a good reputation for providing contract services specialized in metabolomics. Creative Proteomics is ...
-
Creative Proteomics Lipidomics Introduces Glycerophospholipids Analysis Service
Lipidomics, a platform developed by Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, and biotechnological and pharmaceutical companies. Creative Proteomics launches rapid and cost-effective glycerophospholipids analysis based on a highly stable, repeatable, and highly sensitive system for separation, ...
-
Creative Proteomics Metabolomics Expands Service Offering with the Launch of Food Metabolomics Service
Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS based metabolomics services for biomedical research institutions, biotechnology and pharmaceutical companies. The company launches Food Metabolomics Service to assist researchers in conducting faster, more efficient and more accurate food characterization, food composition identification and nutritional ...
-
Creative Proteomics Metabolomics Expands Service Offering with the Launch of Plant Untargeted Metabolomics Service
Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS based metabolomics services for biomedical research institutions, biotechnology and pharmaceutical companies. Based on advanced UPLC-MS/MS systems, the product manager of Creative Proteomics Metabolomics is proud to announce high-efficient and accurate plant untargeted metabolomics analysis service, ...
-
Creative Proteomics Metabolomics Expands Service Offering with the Launch of Microbial Metabolomics Solutions
Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS based metabolomics services for biomedical research institutions, biotechnology and pharmaceutical companies. With deep industry and business process expertise and a good reputation in providing contract services specialized for metabolomics, Creative Proteomics Metabolomics announced the launch of ...
-
Creative Proteomics Lipidomics Launches Microbial Untargeted Lipidomics Service to Promote Your Project
Lipidomics, a division of Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnology and pharmaceutical companies. The product manager has recently announced the fully-developed microbial untargeted lipidomics service for different research purposes. The primary constituents of biological ...
-
Creative Proteomics Lipidomics Launches Ceramides Analysis Service
Lipidomics, a platform developed by Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomic services for biomedical research institutions and biotechnological and pharmaceutical companies. The company recently announced the launch of the ceramides analysis service to help effectively and accurately detect the modification content of ceramides. Ceramide ...
-
28 Teams Chosen for 2nd Annual Medical Capital Innovation Competition
BioEnterprise, in partnership with the Global Center for Health Innovation (Global Center), Cuyahoga County, and Healthcare Information and Management Systems Society (HIMSS) is pleased to announce the participants of the second annual Medical Capital Innovation Competition (MCIC2) to be held at the Global Center for Health Innovation in Cleveland, April 23-24, 2018: The theme of MCIC2 is ...
By Strados Labs
-
Micron signs new research agreement with commercial partner
ATLANTA, July 23, 2018 – Following the successful completion of a first stage of preclinical development work with one of its commercial partners, a leading clinical stage biotechnology company, Micron Biomedical, Inc. (Micron) signed a new research agreement (RA) with its partner to continue the development of a microneedle patch for delivery of the partner’s API. The new RA includes ...
-
AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at Festival of Biologics
IRVINE, Calif. – Mar. 9, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chairman and CEO Dr. Hans S. Keirstead will deliver an opening keynote at the World Immunotherapy Congress, a submeeting of the Festival of Biologics taking place March 9-11 in San Diego. Dr. Keirstead is scheduled to deliver an opening ...
-
AIVITA Biomedical CEO Dr. Hans Keirstead to Give Keynote Address at Advanced Therapies Congress in London
IRVINE, Calif. – Oct. 4, 2021 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chairman and CEO Dr. Hans S. Keirstead will deliver a keynote address at the Advanced Therapies Congress & Expo in London, taking place October 5-6. Dr. Keirstead will speak at the following time and location: Keynote: Cell-based ...
-
AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote At Vaccine World Asia Congress
IRVINE, Calif. – Nov. 16, 2021 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chairman and CEO Dr. Hans S. Keirstead will deliver a keynote at the Vaccine World Asia Congress. The Singapore-based congress is being held virtually November 17-18. Dr. Keirstead’s speaking details are as follows: Keynote: A Fully ...
-
AIVITA Biomedical Announces Publication Detailing 50% Enhanced Survival in Phase 2 GBM Study
IRVINE, Calif. – OCT. 4, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative cell applications, today announced that the Journal of Oncology Research and Therapy has published data from its completed Phase 2 glioblastoma (GBM) study which demonstrates enhanced progression-free survival (PFS). The publication, titled “Enhanced Progression-Free Survival in ...
-
AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Deliver Talk at World Immunotherapy Congress Europe
IRVINE, Calif. – Nov. 8, 2021 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chairman and CEO Dr. Hans S. Keirstead will chair a keynote panel and speak on consecutive days at the World Immunotherapy Congress Europe. The congress is part of the Festival of Biologics taking place in Basel, Switzerland, November 9-11. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you